COMMUNIQUÉS West-GlobeNewswire

-
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems
30/04/2025 -
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025
30/04/2025 -
Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate
30/04/2025 -
Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients
30/04/2025 -
Mountainside Joins Northwell Direct Network to Offer Best-in-Class Addiction Treatment
30/04/2025 -
DEBRICHEM® se voit décerner le prix 2025 IIWCG Achievement Award récompensant l’innovation dans le domaine du soin des plaies
30/04/2025 -
DEBRICHEM® Wins 2025 IIWCG Achievement Award for Innovation in Wound Care
30/04/2025 -
Notice of Annual General Meeting 2025
30/04/2025 -
Essential Pharma strengthens Board with the appointment of Jonathan Arnold as Non-Executive Director
30/04/2025 -
RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA®
30/04/2025 -
Zelluna ASA: Invitation to First Quarter 2025 results webcast presentation
30/04/2025 -
Nanobiotix Announces Presentation of Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer Followed by a Conference Call
30/04/2025 -
Nanobiotix présente les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) dans le cancer du pancréas et organise une conférence téléphonique et webcast
30/04/2025 -
Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025
30/04/2025 -
Présentation des résultats d’une collaboration de recherche en Immuno-Oncologie avec le Centre Léon Bérard - Au congrès annuel de l’AACR 2025
30/04/2025 -
Nicox Provides Full Year 2024 Financial Results
30/04/2025 -
Nicox : Résultats financiers de l’année 2024
30/04/2025 -
CHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings
30/04/2025 -
Augustine Therapeutics builds its Management Team with Virginie Cartage joining as CFO and Dr. Andy Hu as CBO
30/04/2025
Pages